Synergistic antitumor interaction of human monocyte chemotactant protein-1 gene transfer and modulator for tumor-infiltrating macrophages

Pharmaceutical Research

Volumn 15, Issue 5, 1998, Pages 685-689

  Nakashima, Emi ^a,b   Kubota, Yuri ^a   Matsushita, Ryo ^a   Ozaki, Eijiro ^a   Ichimura, Fujio ^a   Kawahara, Sakae ^a   Nakanishi, Isao ^a   Kuno, Kouji ^a   Matsushima, Kouji ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Biological response modulater; Chemokine; Colon 26; Gene transfer; Monocyte chemotactic and activating factor

Indexed keywords

CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER THERAPY; CHEMOTAXIS; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; IMMUNOTHERAPY; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE;

ADENOCARCINOMA; ANIMALS; CHEMOKINE CCL2; COLONIC NEOPLASMS; FEMALE; GENE TRANSFER TECHNIQUES; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; LIPOPOLYSACCHARIDES; LYMPHOCYTES, TUMOR-INFILTRATING; MACROPHAGES; MICE; MICE, INBRED BALB C; TUMOR CELLS, CULTURED;

EID: 0031783589     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011906600304     Document Type: Article

References (19)

1. E. Nakashima, N. Mukaida, Y. Kubota, K. Kuno, K. Yasumoto, F. Ichimura, I. Nakanishi, M. Miyasaka, and K. Matsushima. Human MCAF gene transfer enhances the metastatic capacity of a mouse cachectic adenocarcinoma cell line in vivo. Pharm Res. 12(11):1598-1604 (1995).
2. H. Hock, M. Dorsch, U. Kunzendorf, Z. Qin, T. Diamantstein, and T. Blankenstein. Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma. Proc Natl Acad Sci USA 90(7):2774-8 (1993).
3. Z. Qin, K. S. Kruger, U. Kunzendorf, H. Hock, T. Diamantstein, and T. Blankenstein. Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis. J Exp Med. 178(1):355-60 (1993).
4. D. A. Clark, H. W. Hirte, and R. N. Buick. Human ovarian carcinoma: evidence for patient-related differences in susceptibility to cytotoxic effectors that attack different cellular subpopulations within a tumour. Br J Cancer. 58(4):415-8 (1988).
5. D. D. Taub, P. Proost, W. J. Murphy, M. Anver, D. L. Longo, D. J. Van, and J. J. Oppenheim. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest. 95(3):1370-6 (1995).
6. B. J. Rollins and M. E. Sunday. Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol Cell Biol. 11(6):3125-31 (1991).
7. B. J. Rollins. JE/MCP-1: an early-response gene encodes a monocyte-specific cytokine. Cancer Cells 3(12):517-24 (1991).
8. R. K. Singh and I. J. Fidler. Synergism between human recombinant monocyte chemotactic and activating factor and lipopolysaccharide for activation of antitumor properties in human blood monocytes. Lymphokine Cytokine Res. 12(5):285-91 (1993).
9. S. Huang, R. K. Singh, K. Xie, M. Gutman, K. K. Berry, C. D. Bucana, I. J. Fidler, and E. M. Bar. Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells. Cancer Immunol Immunother. 39(4):231-8 (1994).
10. Y. Tanaka, H. Eda, K. Fujimoto, T. Tanaka, T. Ishikawa, and H. Ishitsuka. Anticachectic activity of 5′-deoxy-5-fluorouridine in a murine tumor cachexia model, colon 26 adenocarcinoma. Cancer Res. 50(15):4528-32 (1990).
11. Y. Furutani, H. Nomura, M. Notake, Y. Oyamada, T. Fukui, M. Yamada, C. G. Larsen, J. J. Oppenheim, and K. Matsushima. Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF). Biochem Biophys Res Commun. 159(1):249-55 (1989).
12. P. Gunning, J. Leavitt, G. Muscat, S. Y. Ng, and L. Kedes. A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc Natl Acad Sci USA. 84(14):4831-5 (1987).
13. C. Chen and H. Okayama. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol. 7(8): 2745-52 (1987).
14. Y. Ko, N. Mukaida, A. Panyutich, N. N. Voitenok, K. Matsushima. T. Kawai, and T. Kasahara. A sensitive enzyme-linked immunosorbent assay for human interleukin-8. J Immunol Methods 149(2):227-35 (1992).
15. Y. Nakano, T. Kasahara, N. Mukaida, Y. C. Ko, M. Nakano, and K. Matsushima. Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor. Infect Immun. 62(2):377-83 (1994).
16. K. Matsushima, C. G. Larsen, G. C. DuBois, and J. J. Oppenheim. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med. 169(4):1485-90 (1989).
17. M. W. Carr, S. J. Roth, E. Luther, S. S. Rose, and T. A. Springer. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 91(9):3652-6 (1994).
18. J. M. Wang, A. Hishinuma, J. J. Oppenheim, and K. Matsushima. Studies of binding and internalization of human recombinant monocyte chemotactic and activating factor (MCAF) by monocytic cells. Cytokine. 5(3):264-75 (1993).
19. R. K. Singh, K. Berry, K. Matsushima, K. Yasumoto, and I. J. Fidler. Synergism between human monocyte chemotactic and activating factor and bacterial products for activation of tumoricidal properties in murine macrophages. J Immunol. 151(5): 2786-93 (1993).